Skip to content

Kura Oncology KURA Earnings yield

Earnings yield at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
3.6%-1.9pp
Amgen logo
AmgenAMGN
4.1%+0.6pp
Exelixis logo
ExelixisEXEL
7.4%+1.1pp
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-11.8%-4.5pp
AbbVie logo
AbbVieABBV
0.9%-0.2pp
Corvus Pharmaceuticals logo
Corvus PharmaceuticalsCRVS
-3.6%-1.6pp

Other financials

Income statement

See full
Revenue$18.3M+29.5%
Gross profit$18.0M
Operating income-$78.8M-21.8%
Net income-$73.3M-27.7%
EPS (diluted)-$0.83-25.8%

Balance sheet

See full
Cash & equivalents$39.1M-23.8%
Total debt$24.3M+25.4%
Total equity$107.9M-70.4%
Total assets$652.6M-12.3%

Cash flow

See full
Operating cash flow-$85.9M-19.4%
CapEx$128.0K-56.2%
Free cash flow-$86.0M-19.1%

Valuation

See full
Market cap$942.78M+81.6%
Enterprise value$927.97M+90.7%
P/S13.2×+3.6×

Profitability

See full
Operating margin-443.5%+103pp
Net margin-411.2%+125pp
FCF margin130.6%+74.1pp

Returns & leverage

See full
Return on equity-124.7%-252pp
Debt / equity0.2×+0.2×
Current ratio6.1×-1.9×

Where this comes from

Calculated from Kura Oncology’s reported figures.

Based on trailing twelve months.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kura Oncology's earnings yield?
Kura Oncology (KURA) reported earnings yield of -41% in Q1 2026.
How has Kura Oncology's earnings yield changed year-over-year?
Kura Oncology's earnings yield decreased by 20.2% year-over-year, from -34.1% to -41%.
What is the long-term trend for Kura Oncology's earnings yield?
Over 5 years (2020 to 2025), Kura Oncology's earnings yield has grown at a 49.4% compound annual growth rate (CAGR), from -4.1% to -30.8%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.